Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of Bao fu kang shuan for p16-positive CIN II
CTR20210286Phase 2Active
- Sponsor
- Hainan Bikai Pharmaceutical Co., Ltd.
- Start
- Sep 2023
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of baofukang shuan in cervical intraepithelial neoplasia (CIN), sponsored by Hainan Bikai Pharmaceutical Co., Ltd.. Started Sep 2023; status: active.
02
Drugs
baofukang shuan
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on CTR20210286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210286.